Eli Lilly Joins Lawsuit Against FDA Over Weight Loss Drug Shortages

Politics

1 year ago

News sources:

Credited from: THEHILL

Eli Lilly is moving to join a lawsuit against the FDA concerning weight loss drugs and their mass-marketing.
The lawsuit originated from the Outsourcing Facilities Association (OFA) over the FDA's shortage declaration for Mounjaro and Zepbound.
The FDA declared the shortage of these GLP-1 medications over in October, prompting the OFA's legal action.
Eli Lilly argues that the OFA's goal to overturn the FDA’s decision threatens its financial interests and investments in manufacturing.
As the FDA stands by its shortage declaration, compounding pharmacies have a deadline until March 19 to cease selling compounded versions of these drugs.

For more details, visit the original article at The Hill.